{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "drug delivery system", "pharmacology", "rutin", "signaling pathways", "therapeutic targets"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32823876", "DateRevised": {"Year": "2024", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "14"}], "Language": ["eng"], "ELocationID": ["2276", "10.3390/cancers12082276"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "12", "Issue": "8", "PubDate": {"Year": "2020", "Month": "Aug", "Day": "14"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach.", "Abstract": {"AbstractText": ["Multiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The conventional therapies used in cancer prevention/treatment suffer from low efficacy, considerable toxicity, and high cost. Hence, the discovery and development of novel multi-targeted agents to attenuate the dysregulated signaling in cancer is of great importance. In recent decades, phytochemicals from dietary and medicinal plants have been successfully introduced as alternative anticancer agents due to their ability to modulate numerous oncogenic and oncosuppressive signaling pathways. Rutin (also known as rutoside, quercetin-3-<i>O</i>-rutinoside and sophorin) is an active plant-derived flavonoid that is widely distributed in various vegetables, fruits, and medicinal plants, including asparagus, buckwheat, apricots, apples, cherries, grapes, grapefruit, plums, oranges, and tea. Rutin has been shown to target various inflammatory, apoptotic, autophagic, and angiogenic signaling mediators, including nuclear factor-\u03baB, tumor necrosis factor-\u03b1, interleukins, light chain 3/Beclin, B cell lymphoma 2 (Bcl-2), Bcl-2 associated X protein, caspases, and vascular endothelial growth factor. A comprehensive and critical analysis of the anticancer potential of rutin and associated molecular targets amongst various cancer types has not been performed previously. Accordingly, the purpose of this review is to present an up-to-date and critical evaluation of multiple cellular and molecular mechanisms through which the anticancer effects of rutin are known to be exerted. The current challenges and limitations as well as future directions of research are also discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah 6714415153, Iran."}], "LastName": "Nouri", "ForeName": "Zeinab", "Initials": "Z"}, {"Identifier": ["0000-0001-8265-8284"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Fakhri", "ForeName": "Sajad", "Initials": "S"}, {"Identifier": ["0000-0003-0568-6956"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran."}], "LastName": "Nouri", "ForeName": "Keyvan", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA."}], "LastName": "Wallace", "ForeName": "Carly E", "Initials": "CE"}, {"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0001-9159-960X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA."}], "LastName": "Bishayee", "ForeName": "Anupam", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393. doi: 10.1038/s41586-020-1969-6.", "ArticleIdList": ["10.1038/s41586-020-1969-6", "PMC7025898", "32025007"]}, {"Citation": "Chen Y., Henson E.S., Xiao W., Huang D., McMillan-Ward E.M., Israels S.J., Gibson S.B. Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia. Autophagy. 2016;12:1029\u20131046. doi: 10.1080/15548627.2016.1164357.", "ArticleIdList": ["10.1080/15548627.2016.1164357", "PMC4922445", "27166522"]}, {"Citation": "Fakhri S., Abbaszadeh F., Jorjani M., Pourgholami M.H. The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: A review study. Nutr. Cancer. 2019:1\u201315. doi: 10.1080/01635581.2019.1673451.", "ArticleIdList": ["10.1080/01635581.2019.1673451", "31648565"]}, {"Citation": "Ochwang\u2019i D.O., Kimwele C.N., Oduma J.A., Gathumbi P.K., Mbaria J.M., Kiama S.G. Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya. J. Ethnopharmacol. 2014;151:1040\u20131055. doi: 10.1016/j.jep.2013.11.051.", "ArticleIdList": ["10.1016/j.jep.2013.11.051", "24362078"]}, {"Citation": "Slattery M.L., Herrick J.S., Mullany L.E., Samowitz W.S., Sevens J.R., Sakoda L., Wolff R.K. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer. 2017;56:769\u2013787. doi: 10.1002/gcc.22481.", "ArticleIdList": ["10.1002/gcc.22481", "PMC5597468", "28675510"]}, {"Citation": "Croce C.M., Reed J.C. Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res. 2016;76:5914\u20135920. doi: 10.1158/0008-5472.CAN-16-1248.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-1248", "PMC5117672", "27694602"]}, {"Citation": "Monkkonen T., Debnath J. Inflammatory signaling cascades and autophagy in cancer. Autophagy. 2018;14:190\u2013198. doi: 10.1080/15548627.2017.1345412.", "ArticleIdList": ["10.1080/15548627.2017.1345412", "PMC5902219", "28813180"]}, {"Citation": "Postovit L., Widmann C., Huang P., Gibson S.B. Harnessing oxidative stress as an innovative target for cancer therapy. Hindawi. 2018 doi: 10.1155/2018/6135739.", "ArticleIdList": ["10.1155/2018/6135739", "PMC5994291", "29977457"]}, {"Citation": "Mileo A.M., Miccadei S. Polyphenols as modulator of oxidative stress in cancer disease: New therapeutic strategies. Oxid. Med. Cell Longev. 2016;2016 doi: 10.1155/2016/6475624.", "ArticleIdList": ["10.1155/2016/6475624", "PMC4663347", "26649142"]}, {"Citation": "Williams G.H., Stoeber K. The cell cycle and cancer. J. Pathol. 2012;226:352\u2013364. doi: 10.1002/path.3022.", "ArticleIdList": ["10.1002/path.3022", "21990031"]}, {"Citation": "Huang J., Gao L., Li B., Liu C., Hong S., Min J., Hong L. Knockdown of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) promotes autophagy and inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian target of rapamycin (mTOR) signaling pathway in ovarian cancer cells. Med. Sci. Monit. 2019;25:4250\u20134263. doi: 10.12659/MSM.915730.", "ArticleIdList": ["10.12659/MSM.915730", "PMC6573092", "31175269"]}, {"Citation": "Amani H., Ajami M., Maleki S.N., Pazoki-Toroudi H., Daglia M., Sokeng A.J.T., Di Lorenzo A., Nabavi S.F., Devi K.P., Nabavi S.M. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie. 2017;142:63\u201379. doi: 10.1016/j.biochi.2017.08.007.", "ArticleIdList": ["10.1016/j.biochi.2017.08.007", "28807562"]}, {"Citation": "Peluso I., Yarla N.S., Ambra R., Pastore G., Perry G. MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents. Semin. Cancer Biol. 2019;56:185\u2013195. doi: 10.1016/j.semcancer.2017.09.002.", "ArticleIdList": ["10.1016/j.semcancer.2017.09.002", "28912082"]}, {"Citation": "Park M.H., Hong J.T. Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016;5:15. doi: 10.3390/cells5020015.", "ArticleIdList": ["10.3390/cells5020015", "PMC4931664", "27043634"]}, {"Citation": "Atsaves V., Leventaki V., Rassidakis G.Z., Claret F.X. AP-1 transcription factors as regulators of immune responses in cancer. Cancers. 2019;11:1037. doi: 10.3390/cancers11071037.", "ArticleIdList": ["10.3390/cancers11071037", "PMC6678392", "31340499"]}, {"Citation": "Marelli G., Sica A., Vannucci L., Allavena P. Inflammation as target in cancer therapy. Curr. Opin. Pharmacol. 2017;35:57\u201365. doi: 10.1016/j.coph.2017.05.007.", "ArticleIdList": ["10.1016/j.coph.2017.05.007", "28618326"]}, {"Citation": "Mohammadi M., Jaafari M., Mirzaei H., Mirzaei H. Mesenchymal stem cell: A new horizon in cancer gene therapy. Cancer Gene Ther. 2016;23:285\u2013286. doi: 10.1038/cgt.2016.35.", "ArticleIdList": ["10.1038/cgt.2016.35", "27650780"]}, {"Citation": "Fujishiro T., Nonoguchi N., Pavliukov M., Ohmura N., Kawabata S., Park Y., Kajimoto Y., Ishikawa T., Nakano I., Kuroiwa T. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents. Photodiagnosis Photodyn. Ther. 2018;24:58\u201368. doi: 10.1016/j.pdpdt.2018.07.004.", "ArticleIdList": ["10.1016/j.pdpdt.2018.07.004", "29990642"]}, {"Citation": "Davatgaran-Taghipour Y., Masoomzadeh S., Farzaei M.H., Bahramsoltani R., Karimi-Soureh Z., Rahimi R., Abdollahi M. Polyphenol nanoformulations for cancer therapy: Experimental evidence and clinical perspective. Int. J. Nanomed. 2017;12:2689. doi: 10.2147/IJN.S131973.", "ArticleIdList": ["10.2147/IJN.S131973", "PMC5388197", "28435252"]}, {"Citation": "Cragg G.M., Pezzuto J.M. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract. 2016;25:41\u201359. doi: 10.1159/000443404.", "ArticleIdList": ["10.1159/000443404", "PMC5588531", "26679767"]}, {"Citation": "Castillo R.R., Colilla M., Vallet-Reg\u00ed M. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opin. Drug Deliv. 2017;14:229\u2013243. doi: 10.1080/17425247.2016.1211637.", "ArticleIdList": ["10.1080/17425247.2016.1211637", "27402029"]}, {"Citation": "Khurana R.K., Jain A., Jain A., Sharma T., Singh B., Kesharwani P. Administration of antioxidants in cancer: Debate of the decade. Drug Discov. Today. 2018;23:763\u2013770. doi: 10.1016/j.drudis.2018.01.021.", "ArticleIdList": ["10.1016/j.drudis.2018.01.021", "29317341"]}, {"Citation": "Bishayee A., Sethi G. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin. Cancer Biol. 2016;40\u201341:1\u20133. doi: 10.1016/j.semcancer.2016.08.006.", "ArticleIdList": ["10.1016/j.semcancer.2016.08.006", "27565447"]}, {"Citation": "Bordoloi D., Roy N.K., Monisha J., Padmavathi G., Kunnumakkara A. Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far. Recent Pat. Anticancer Drug Discov. 2016;11:67\u201397. doi: 10.2174/1574892810666151020101706.", "ArticleIdList": ["10.2174/1574892810666151020101706", "26537958"]}, {"Citation": "Korkina L., De Luca C., Kostyuk V., Pastore S. Plant polyphenols and tumors: From mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments. Curr. Med. Chem. 2009;16:3943\u20133965. doi: 10.2174/092986709789352312.", "ArticleIdList": ["10.2174/092986709789352312", "19747130"]}, {"Citation": "Fakhri S., Khodamorady M., Naseri M., Farzaei M.H., Khan H. The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism. Pharmacol. Res. 2020;159:104895. doi: 10.1016/j.phrs.2020.104895.", "ArticleIdList": ["10.1016/j.phrs.2020.104895", "32422342"]}, {"Citation": "Braicu C., Zanoaga O., Zimta A.-A., Tigu A.B., Kilpatrick K.L., Bishayee A., Nabavi S.M., Berindan-Neagoe I. Natural compounds modulate the crosstalk between apoptosis-and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin. Cancer Biol. 2020 doi: 10.1016/j.semcancer.2020.05.015. in press.", "ArticleIdList": ["10.1016/j.semcancer.2020.05.015", "32502598"]}, {"Citation": "Satari A., Amini S.A., Raeisi E., Lemoigne Y., Heidarian E. Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in PC3 cancer cells through the modulation of P53 gene expression. Adv. Pharm. Bull. 2019;9:462. doi: 10.15171/apb.2019.055.", "ArticleIdList": ["10.15171/apb.2019.055", "PMC6773939", "31592435"]}, {"Citation": "ben Sghaier M., Pagano A., Mousslim M., Ammari Y., Kovacic H., Luis J. Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells. Biomed. Pharmacother. 2016;84:1972\u20131978. doi: 10.1016/j.biopha.2016.11.001.", "ArticleIdList": ["10.1016/j.biopha.2016.11.001", "27829548"]}, {"Citation": "Song H.-l., Zhang X., Wang W.-z., Liu R.-h., Zhao K., Liu M.-y., Gong W.-m., Ning B. Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase pathway. Neural Regen Res. 2018;13:128.", "ArticleIdList": ["PMC5840978", "29451217"]}, {"Citation": "Gautam R., Singh M., Gautam S., Rawat J.K., Saraf S.A., Kaithwas G. Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects. BMC Complement. Altern. Med. 2016;16:99. doi: 10.1186/s12906-016-1069-1.", "ArticleIdList": ["10.1186/s12906-016-1069-1", "PMC4785621", "26965456"]}, {"Citation": "Yang C.-Y., Hsiu S.-L., Wen K.-C., Lin S.-P., Tsai S.-Y. Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J. Food Drug Anal. 2005;13 doi: 10.38212/2224-6614.2517.", "ArticleIdList": ["10.38212/2224-6614.2517"]}, {"Citation": "Zheng Y., Zhao Z., Fan L., Meng S., Song C., Qiu L., Xu P., Chen J. Dietary supplementation with rutin has pro-/anti-inflammatory effects in the liver of juvenile GIFT tilapia, Oreochromis niloticus. Fish. Shellfish Immunol. 2017;64:49\u201355. doi: 10.1016/j.fsi.2017.03.014.", "ArticleIdList": ["10.1016/j.fsi.2017.03.014", "28279789"]}, {"Citation": "Khajevand-Khazaei M.-R., Mohseni-Moghaddam P., Hosseini M., Gholami L., Baluchnejadmojarad T., Roghani M. Rutin, a quercetin glycoside, alleviates acute endotoxemic kidney injury in C57BL/6 mice via suppression of inflammation and up-regulation of antioxidants and SIRT1. Eur. J. Pharmacol. 2018;833:307\u2013313. doi: 10.1016/j.ejphar.2018.06.019.", "ArticleIdList": ["10.1016/j.ejphar.2018.06.019", "29920283"]}, {"Citation": "Prasad R., Prasad S.B. A review on the chemistry and biological properties of Rutin, a promising nutraceutical agent. Asian J. Pharm. Pharmacol. 2019;5:1\u201320. doi: 10.31024/ajpp.2019.5.s1.1.", "ArticleIdList": ["10.31024/ajpp.2019.5.s1.1"]}, {"Citation": "Ganeshpurkar A., Saluja A.K. The pharmacological potential of rutin. Saudi. Pharm. J. 2017;25:149\u2013164. doi: 10.1016/j.jsps.2016.04.025.", "ArticleIdList": ["10.1016/j.jsps.2016.04.025", "PMC5355559", "28344465"]}, {"Citation": "Perk A.A., Shatynska-Mytsyk I., Ger\u00e7ek Y.C., Bozta\u015f K., Yazgan M., Fayyaz S., Farooqi A.A. Rutin mediated targeting of signaling machinery in cancer cells. Cancer Cell Int. 2014;14:1\u20135. doi: 10.1186/s12935-014-0124-6.", "ArticleIdList": ["10.1186/s12935-014-0124-6", "PMC4260193", "25493075"]}, {"Citation": "Greten F.R., Grivennikov S.I. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341. doi: 10.1016/j.immuni.2019.06.025.", "ArticleIdList": ["10.1016/j.immuni.2019.06.025", "PMC6831096", "31315034"]}, {"Citation": "Mantovani A. Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 2010;10:369\u2013373. doi: 10.2174/156652410791316968.", "ArticleIdList": ["10.2174/156652410791316968", "20455855"]}, {"Citation": "Siveen K.S., Sikka S., Surana R., Dai X., Zhang J., Kumar A.P., Tan B.K., Sethi G., Bishayee A. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim. Biophys. Acta Rev. Cancer. 2014;1845:136\u2013154. doi: 10.1016/j.bbcan.2013.12.005.", "ArticleIdList": ["10.1016/j.bbcan.2013.12.005", "24388873"]}, {"Citation": "Tsao S.-m., Hsia T.-c., Yin M.-c. Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-\u03baB pathways. Nutr. Cancer. 2014;66:1331\u20131341. doi: 10.1080/01635581.2014.956259.", "ArticleIdList": ["10.1080/01635581.2014.956259", "25356681"]}, {"Citation": "de Pasquali M.A.B., Gelain D.P., Zeid\u00e1n-Chuli\u00e1 F., Pires A.S., Gasparotto J., Terra S.R., Moreira J.C.F. Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells. Cell Signal. 2013;25:939\u2013954. doi: 10.1016/j.cellsig.2013.01.013.", "ArticleIdList": ["10.1016/j.cellsig.2013.01.013", "23333461"]}, {"Citation": "Sun Y., Zhang L., Zhang M., Li R., Li Y., Hu X., Wang S., Bao Z. Characterization of three mitogen-activated protein kinases (MAPK) genes reveals involvement of ERK and JNK, not p38 in defense against bacterial infection in Yesso scallop Patinopecten yessoensis. Fish Shellfish Immunol. 2016;54:507\u2013515. doi: 10.1016/j.fsi.2016.04.139.", "ArticleIdList": ["10.1016/j.fsi.2016.04.139", "27155450"]}, {"Citation": "Ye J., Piao H., Jiang J., Jin G., Zheng M., Yang J., Jin X., Sun T., Choi Y.H., Li L. Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-\u03baB and Nrf2/HO-1 pathways. Sci. Rep. 2017;7:1\u201313. doi: 10.1038/s41598-017-12252-3.", "ArticleIdList": ["10.1038/s41598-017-12252-3", "PMC5605538", "28928455"]}, {"Citation": "Jhaveri K., Teplinsky E., Silvera D., Valeta-Magara A., Arju R., Giashuddin S., Sarfraz Y., Alexander M., Darvishian F., Levine P.H. Hyperactivated mTOR and JAK2/STAT3 pathways: Molecular drivers and potential therapeutic targets of inflammatory and invasive ductal breast cancers after neoadjuvant chemotherapy. Clin. Breast Cancer. 2016;16:113\u2013122.e1. doi: 10.1016/j.clbc.2015.11.006.", "ArticleIdList": ["10.1016/j.clbc.2015.11.006", "PMC4794410", "26774497"]}, {"Citation": "Ebrahim H.Y., Elsayed H.E., Mohyeldin M.M., Akl M.R., Bhattacharjee J., Egbert S., Sayed K.A.E. Norstictic acid inhibits breast cancer cell proliferation, migration, invasion, and in vivo invasive growth through targeting C-Met. Phytother. Res. 2016;30:557\u2013566. doi: 10.1002/ptr.5551.", "ArticleIdList": ["10.1002/ptr.5551", "PMC5045260", "26744260"]}, {"Citation": "Pothula S.P., Xu Z., Goldstein D., Merrett N., Pirola R.C., Wilson J.S., Apte M.V. Targeting the HGF/c-MET pathway: Stromal remodelling in pancreatic cancer. Oncotarget. 2017;8:76722. doi: 10.18632/oncotarget.20822.", "ArticleIdList": ["10.18632/oncotarget.20822", "PMC5652738", "29100344"]}, {"Citation": "Vahidnezhad H., Youssefian L., Uitto J. Molecular genetics of the PI3K-AKT-mTOR pathway in genodermatoses: Diagnostic implications and treatment opportunities. J. Invest. Dermatol. 2016;136:15\u201323. doi: 10.1038/JID.2015.331.", "ArticleIdList": ["10.1038/JID.2015.331", "26763419"]}, {"Citation": "Kim K.-Y., Yu S.-N., Lee S.-Y., Chun S.-S., Choi Y.-L., Park Y.-M., Song C.S., Chatterjee B., Ahn S.-C. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem. Biophys. Res. Commun. 2011;413:80\u201386. doi: 10.1016/j.bbrc.2011.08.054.", "ArticleIdList": ["10.1016/j.bbrc.2011.08.054", "21871443"]}, {"Citation": "Kongara S., Karantza V. The interplay between autophagy and ROS in tumorigenesis. Front. Oncol. 2012;2:171. doi: 10.3389/fonc.2012.00171.", "ArticleIdList": ["10.3389/fonc.2012.00171", "PMC3502876", "23181220"]}, {"Citation": "Ahmed A.M. Oxidative Stress in Lung Diseases. Springer; Berlin/Heidelberg, Germany: 2019. The dual role of oxidative stress in lung cancer; pp. 99\u2013113."}, {"Citation": "Menegon S., Columbano A., Giordano S. The dual roles of NRF2 in cancer. Trends Mol. Med. 2016;22:578\u2013593. doi: 10.1016/j.molmed.2016.05.002.", "ArticleIdList": ["10.1016/j.molmed.2016.05.002", "27263465"]}, {"Citation": "Matsuura K., Canfield K., Feng W., Kurokawa M. Metabolic regulation of apoptosis in cancer. Int. Rev. Cell Mol. Biol. 2016;327:43\u201387.", "ArticleIdList": ["PMC5819894", "27692180"]}, {"Citation": "Safa A.R. Oncogenomics. Elsevier; Amsterdam, The Netherlands: 2019. Cancer stem cells, apoptosis pathways and mechanisms of death resistance; pp. 89\u2013101."}, {"Citation": "Hongmei Z. Apoptosis and Medicine. InTechOpen; London, UK: 2012. Extrinsic and intrinsic apoptosis signal pathway review."}, {"Citation": "Adams J.M., Cory S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ. 2018;25:27\u201336. doi: 10.1038/cdd.2017.161.", "ArticleIdList": ["10.1038/cdd.2017.161", "PMC5729526", "29099483"]}, {"Citation": "Akl M.R., Elsayed H.E., Ebrahim H.Y., Haggag E.G., Kamal A.M., Sayed K.A.E. 3-O-[N-(p-fluorobenzenesulfonyl)-carbamoyl]-oleanolic acid, a semisynthetic analog of oleanolic acid, induces apoptosis in breast cancer cells. Eur. J. Pharmacol. 2014;740:209\u2013217. doi: 10.1016/j.ejphar.2014.07.011.", "ArticleIdList": ["10.1016/j.ejphar.2014.07.011", "25046839"]}, {"Citation": "Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene. 2003;22:9030\u20139040. doi: 10.1038/sj.onc.1207116.", "ArticleIdList": ["10.1038/sj.onc.1207116", "14663481"]}, {"Citation": "Nikoletopoulou V., Markaki M., Palikaras K., Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta Mol. Cell Res. 2013;1833:3448\u20133459. doi: 10.1016/j.bbamcr.2013.06.001.", "ArticleIdList": ["10.1016/j.bbamcr.2013.06.001", "23770045"]}, {"Citation": "Elena-Real C.A., D\u00edaz-Quintana A., Gonz\u00e1lez-Arzola K., Vel\u00e1zquez-Campoy A., Orz\u00e1ez M., L\u00f3pez-Rivas A., Gil-Caballero S., Miguel \u00c1., D\u00edaz-Moreno I. Cytochrome c speeds up caspase cascade activation by blocking 14-3-3\u03b5-dependent Apaf-1 inhibition. Cell Death Dis. 2018;9:1\u201312. doi: 10.1038/s41419-018-0408-1.", "ArticleIdList": ["10.1038/s41419-018-0408-1", "PMC5840378", "29511177"]}, {"Citation": "Aubrey B.J., Kelly G.L., Janic A., Herold M.J., Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25:104\u2013113. doi: 10.1038/cdd.2017.169.", "ArticleIdList": ["10.1038/cdd.2017.169", "PMC5729529", "29149101"]}, {"Citation": "Wu G.S. The functional interactions between the MAPK and p53 signaling pathways. Cancer Biol. Ther. 2004;3:156\u2013161. doi: 10.4161/cbt.3.2.614.", "ArticleIdList": ["10.4161/cbt.3.2.614", "14764989"]}, {"Citation": "Qin J.-Z., Bacon P., Chaturvedi V., Nickoloff B.J. Role of NF-\u03baB activity in apoptotic response of keratinocytes mediated by interferon-\u03b3, tumor necrosis factor-\u03b1, and tumor-necrosis-factor-related apoptosis-inducing ligand. J. Invest. Dermatol. 2001;117:898\u2013907. doi: 10.1046/j.0022-202x.2001.01477.x.", "ArticleIdList": ["10.1046/j.0022-202x.2001.01477.x", "11676830"]}, {"Citation": "Los M., Mozoluk M., Ferrari D., Stepczynska A., Stroh C., Renz A., Herceg Z., Wang Z.-Q., Schulze-Osthoff K. Activation and caspase-mediated inhibition of PARP: A molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell. 2002;13:978\u2013988. doi: 10.1091/mbc.01-05-0272.", "ArticleIdList": ["10.1091/mbc.01-05-0272", "PMC99613", "11907276"]}, {"Citation": "Wang Y., Chen B., Wang Z., Zhang W., Hao K., Chen Y., Li K., Wang T., Xie Y., Huang Z. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement. Oncotarget. 2016;7:82851. doi: 10.18632/oncotarget.12654.", "ArticleIdList": ["10.18632/oncotarget.12654", "PMC5347737", "27756877"]}, {"Citation": "Yun C.W., Lee S.H. The roles of autophagy in cancer. Int. J. Mol. Sci. 2018;19:3466. doi: 10.3390/ijms19113466.", "ArticleIdList": ["10.3390/ijms19113466", "PMC6274804", "30400561"]}, {"Citation": "Rao S., Tortola L., Perlot T., Wirnsberger G., Novatchkova M., Nitsch R., Sykacek P., Frank L., Schramek D., Komnenovic V. A dual role for autophagy in a murine model of lung cancer. Nat. Commun. 2014;5:1\u201315. doi: 10.1038/ncomms4056.", "ArticleIdList": ["10.1038/ncomms4056", "24445999"]}, {"Citation": "Singh S.S., Vats S., Chia A.Y.-Q., Tan T.Z., Deng S., Ong M.S., Arfuso F., Yap C.T., Goh B.C., Sethi G. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142\u20131158. doi: 10.1038/s41388-017-0046-6.", "ArticleIdList": ["10.1038/s41388-017-0046-6", "29255248"]}, {"Citation": "Dower C.M., Wills C.A., Frisch S.M., Wang H.-G. Mechanisms and context underlying the role of autophagy in cancer metastasis. Autophagy. 2018;14:1110\u20131128. doi: 10.1080/15548627.2018.1450020.", "ArticleIdList": ["10.1080/15548627.2018.1450020", "PMC6103720", "29863947"]}, {"Citation": "Xu L., Zhang X., Li Y., Lu S., Lu S., Li J., Wang Y., Tian X., Wei J.-j., Shao C. Neferine induces autophagy of human ovarian cancer cells via p38 MAPK/JNK activation. Tumor. Biol. 2016;37:8721\u20138729. doi: 10.1007/s13277-015-4737-8.", "ArticleIdList": ["10.1007/s13277-015-4737-8", "26738868"]}, {"Citation": "Kim K.-Y., Park K.-I., Kim S.-H., Yu S.-N., Park S.-G., Kim Y.W., Seo Y.-K., Ma J.-Y., Ahn S.-C. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int. J. Mol. Sci. 2017;18:1088. doi: 10.3390/ijms18051088.", "ArticleIdList": ["10.3390/ijms18051088", "PMC5454997", "28524116"]}, {"Citation": "Jung C.H., Ro S.-H., Cao J., Otto N.M., Kim D.-H. mTOR regulation of autophagy. FEBS Lett. 2010;584:1287\u20131295. doi: 10.1016/j.febslet.2010.01.017.", "ArticleIdList": ["10.1016/j.febslet.2010.01.017", "PMC2846630", "20083114"]}, {"Citation": "Kreft I., Fabjan N., Yasumoto K. Rutin content in buckwheat (Fagopyrum esculentum Moench) food materials and products. Food Chem. 2006;98:508\u2013512. doi: 10.1016/j.foodchem.2005.05.081.", "ArticleIdList": ["10.1016/j.foodchem.2005.05.081"]}, {"Citation": "Patel K., Patel D.K. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Elsevier; Amsterdam, The Netherlands: 2019. The beneficial role of rutin, a naturally occurring flavonoid in health promotion and disease prevention: A systematic review and update; pp. 457\u2013479."}, {"Citation": "Chua L.S. A review on plant-based rutin extraction methods and its pharmacological activities. J. Ethnopharmacol. 2013;150:805\u2013817. doi: 10.1016/j.jep.2013.10.036.", "ArticleIdList": ["10.1016/j.jep.2013.10.036", "24184193"]}, {"Citation": "Gull\u00f3n B., L\u00fa-Chau T.A., Moreira M.T., Lema J.M., Eibes G. Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci. Technol. 2017;67:220\u2013235. doi: 10.1016/j.tifs.2017.07.008.", "ArticleIdList": ["10.1016/j.tifs.2017.07.008"]}, {"Citation": "Abdullah Y., Schneider B., Petersen M. Occurrence of rosmarinic acid, chlorogenic acid and rutin in Marantaceae species. Phytochem. Lett. 2008;1:199\u2013203. doi: 10.1016/j.phytol.2008.09.010.", "ArticleIdList": ["10.1016/j.phytol.2008.09.010"]}, {"Citation": "Kreft S., \u0160trukelj B., Gaber\u0161\u010dik A., Kreft I. Rutin in buckwheat herbs grown at different UV-B radiation levels: Comparison of two UV spectrophotometric and an HPLC method. J. Exp. Bot. 2002;53:1801\u20131804. doi: 10.1093/jxb/erf032.", "ArticleIdList": ["10.1093/jxb/erf032", "12147730"]}, {"Citation": "Harborne J.B., Williams C.A. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481\u2013504. doi: 10.1016/S0031-9422(00)00235-1.", "ArticleIdList": ["10.1016/S0031-9422(00)00235-1", "11130659"]}, {"Citation": "Abdel-Ghaffar O., Mahmoud S.T., Said A.A., Sanad F.A.-A.Y. Hepatoprotective effect of rutin against oxidative stress of Isoniazid in albino rats. Int. J. Pharmacol. 2017;13:516\u2013528."}, {"Citation": "Domitrovi\u0107 R., Jakovac H., Marchesi V.V., Vladimir-Kne\u017eevi\u0107 S., Cvijanovi\u0107 O., Tadi\u0107 \u017d., Romi\u0107 \u017d., Raheli\u0107 D. Differential hepatoprotective mechanisms of rutin and quercetin in CCl 4-intoxicated BALB/cN mice. Acta Pharmacol. Sin. 2012;33:1260\u20131270. doi: 10.1038/aps.2012.62.", "ArticleIdList": ["10.1038/aps.2012.62", "PMC4002705", "22902988"]}, {"Citation": "Lin Q., Chen X.-Y., Zhang J., Yuan Y.-L., Zhao W., Wei B. Upregulation of SIRT1 contributes to the cardioprotective effect of Rutin against myocardial ischemia-reperfusion injury in rats. J. Funct. Foods. 2018;46:227\u2013236. doi: 10.1016/j.jff.2018.05.007.", "ArticleIdList": ["10.1016/j.jff.2018.05.007"]}, {"Citation": "Sheu J.-R., Hsiao G., Chou P.-H., Shen M.-Y., Chou D.-S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J. Agric. Food Chem. 2004;52:4414\u20134418. doi: 10.1021/jf040059f.", "ArticleIdList": ["10.1021/jf040059f", "15237945"]}, {"Citation": "Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed. Pharmacother. 2017;96:305\u2013312. doi: 10.1016/j.biopha.2017.10.001.", "ArticleIdList": ["10.1016/j.biopha.2017.10.001", "29017142"]}, {"Citation": "Wang W., Wu Q.-h., Sui Y., Wang Y., Qiu X. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. Biomed. Pharmacother. 2017;86:32\u201340. doi: 10.1016/j.biopha.2016.11.134.", "ArticleIdList": ["10.1016/j.biopha.2016.11.134", "27936392"]}, {"Citation": "Ugusman A., Zakaria Z., Chua K.H., Nordin N.A.M.M., Mahdy Z.A. Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells. Sci. World J. 2014;2014 doi: 10.1155/2014/169370.", "ArticleIdList": ["10.1155/2014/169370", "PMC4095739", "25093198"]}, {"Citation": "Wu J., Maoqiang L., Fan H., Zhenyu B., Qifang H., Xuepeng W., Liulong Z. Rutin attenuates neuroinflammation in spinal cord injury rats. J. Surg. Res. 2016;203:331\u2013337. doi: 10.1016/j.jss.2016.02.041.", "ArticleIdList": ["10.1016/j.jss.2016.02.041", "27363641"]}, {"Citation": "Enogieru A.B., Haylett W., Hiss D.C., Bardien S., Ekpo O.E. Rutin as a potent antioxidant: Implications for neurodegenerative disorders. Oxid. Med. Cell Longev. 2018;2018 doi: 10.1155/2018/6241017.", "ArticleIdList": ["10.1155/2018/6241017", "PMC6040293", "30050657"]}, {"Citation": "Budzynska B., Faggio C., Kruk-Slomka M., Samec D., Nabavi S.F., Sureda A., Devi K.P., Nabavi S.M. Rutin as neuroprotective agent: From bench to bedside. Curr. Med. Chem. 2019;26:5152\u20135164. doi: 10.2174/0929867324666171003114154.", "ArticleIdList": ["10.2174/0929867324666171003114154", "28971760"]}, {"Citation": "Radwan R.R., Fattah S.M.A. Mechanisms involved in the possible nephroprotective effect of rutin and low dose \u03b3 irradiation against cisplatin-induced nephropathy in rats. J. Photochem. Photobiol. B. 2017;169:56\u201362. doi: 10.1016/j.jphotobiol.2017.02.022.", "ArticleIdList": ["10.1016/j.jphotobiol.2017.02.022", "28282556"]}, {"Citation": "Qu S., Dai C., Lang F., Hu L., Tang Q., Wang H., Zhang Y., Hao Z. Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats. Antimicrob. Agents Chemother. 2019;63 doi: 10.1128/AAC.01545-18.", "ArticleIdList": ["10.1128/AAC.01545-18", "PMC6325182", "30397060"]}, {"Citation": "Caglayan C., Kandemir F.M., Yildirim S., Kucukler S., Eser G. Rutin protects mercuric chloride-induced nephrotoxicity via targeting of aquaporin 1 level, oxidative stress, apoptosis and inflammation in rats. J. Trace Elem. Med. Biol. 2019;54:69\u201378. doi: 10.1016/j.jtemb.2019.04.007.", "ArticleIdList": ["10.1016/j.jtemb.2019.04.007", "31109623"]}, {"Citation": "Liu Q., Pan R., Ding L., Zhang F., Hu L., Ding B., Zhu L., Xia Y., Dou X. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Int. Immunopharmacol. 2017;49:132\u2013141. doi: 10.1016/j.intimp.2017.05.026.", "ArticleIdList": ["10.1016/j.intimp.2017.05.026", "28577437"]}, {"Citation": "Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.", "ArticleIdList": ["10.1371/journal.pmed.1000097", "PMC2707599", "19621072"]}, {"Citation": "Kravchenko J., Akushevich I., Seewaldt V.L., Abernethy A.P., Lyerly H.K. Breast cancer as heterogeneous disease: Contributing factors and carcinogenesis mechanisms. Breast Cancer Res. Treat. 2011;128:483\u2013493. doi: 10.1007/s10549-011-1347-z.", "ArticleIdList": ["10.1007/s10549-011-1347-z", "21225455"]}, {"Citation": "Sinha D., Biswas J., Nabavi S.M., Bishayee A. Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond. Semin. Cancer Biol. 2017;46:33\u201354. doi: 10.1016/j.semcancer.2017.04.001.", "ArticleIdList": ["10.1016/j.semcancer.2017.04.001", "28396252"]}, {"Citation": "Telang N.T., Li G., Katdare M., Sepkovic D.W., Bradlow H.L., Wong G.Y. The nutritional herb Epimedium grandiflorum inhibits the growth in a model for the Luminal A molecular subtype of breast cancer. Oncol. Lett. 2017;13:2477\u20132482. doi: 10.3892/ol.2017.5720.", "ArticleIdList": ["10.3892/ol.2017.5720", "PMC5403390", "28454423"]}, {"Citation": "Agelaki S., Dragolia M., Markonanolaki H., Alkahtani S., Stournaras C., Georgoulias V., Kallergi G. Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients. Oncotarget. 2017;8:5309. doi: 10.18632/oncotarget.14144.", "ArticleIdList": ["10.18632/oncotarget.14144", "PMC5354910", "28029660"]}, {"Citation": "Bianchini G., Balko J.M., Mayer I.A., Sanders M.E., Gianni L. Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 2016;13:674. doi: 10.1038/nrclinonc.2016.66.", "ArticleIdList": ["10.1038/nrclinonc.2016.66", "PMC5461122", "27184417"]}, {"Citation": "Mohyeldin M.M., Akl M.R., Ebrahim H.Y., Dragoi A.M., Dykes S., Cardelli J.A., Sayed K.A.E. The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor. Oncotarget. 2016;7:32247. doi: 10.18632/oncotarget.8681.", "ArticleIdList": ["10.18632/oncotarget.8681", "PMC5078011", "27086914"]}, {"Citation": "Elsayed H.E., Ebrahim H.Y., Mohyeldin M.M., Siddique A.B., Kamal A.M., Haggag E.G., El Sayed K.A. Rutin as a novel c-Met inhibitory lead for the control of triple negative breast malignancies. Nutr. Cancer. 2017;69:1256\u20131271. doi: 10.1080/01635581.2017.1367936.", "ArticleIdList": ["10.1080/01635581.2017.1367936", "PMC6193555", "29083228"]}, {"Citation": "Hasani N.A.H., Amin I.M., Kamaludin R., Rosdyd N.M.M.N.M., Ibahim M.J., Kadir S.H.S.A. P53 and cyclin B1 mediate apoptotic effects of apigenin and rutin in ER\u03b1+-breast cancer MCF-7 cells. J. Teknol. 2018;80 doi: 10.11113/jt.v80.10704.", "ArticleIdList": ["10.11113/jt.v80.10704"]}, {"Citation": "Saleh A., ElFayoumi H.M., Youns M., Barakat W. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn Schmiedeberg\u2019s Arch. Pharmacol. 2019;392:165\u2013175. doi: 10.1007/s00210-018-1579-0.", "ArticleIdList": ["10.1007/s00210-018-1579-0", "30465055"]}, {"Citation": "Iriti M., Kubina R., Cochis A., Sorrentino R., Varoni E.M., Kaba\u0142a-Dzik A., Azzimonti B., Dziedzic A., Rimondini L., Wojtyczka R.D. Rutin, a quercetin glycoside, restores chemosensitivity in human breast cancer cells. Phytother. Res. 2017;31:1529\u20131538. doi: 10.1002/ptr.5878.", "ArticleIdList": ["10.1002/ptr.5878", "28752532"]}, {"Citation": "Mohana S., Ganesan M., Rajendra Prasad N., Ananthakrishnan D., Velmurugan D. Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines. BMC Cancer. 2018;18:1168. doi: 10.1186/s12885-018-5103-1.", "ArticleIdList": ["10.1186/s12885-018-5103-1", "PMC6260573", "30477461"]}, {"Citation": "Schindler R., Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 2006;136:1477\u20131482. doi: 10.1093/jn/136.6.1477.", "ArticleIdList": ["10.1093/jn/136.6.1477", "16702307"]}, {"Citation": "Yang S., Zhang H., Yang X., Zhao H., Zhu Y. Evaluation of antiproliferative activities of rutin on human colon cancer lovo cells and breast cancer MCF-7 cells. Anal. Quant. Cytopathol. Histopathol. 2017;39:99\u2013107."}, {"Citation": "Zhu H., Wang Y., Liu D., Sun X., Wang F. Vanadium-rutin complex sensitizes breast cancer cells via modulation of p53/BAx/BCl2/VEGF correlated with apoptotic events. Acta Pol. Pharm. Drug Res. 2020;77:89\u201398. doi: 10.32383/appdr/115158.", "ArticleIdList": ["10.32383/appdr/115158"]}, {"Citation": "Kunjiappan S., Theivendran P., Baskararaj S., Sankaranarayanan B., Palanisamy P., Saravanan G., Arunachalam S., Sankaranarayanan M., Natarajan J., Somasundaram B. Modeling a pH-sensitive Zein-co-acrylic acid hybrid hydrogels loaded 5-fluorouracil and rutin for enhanced anticancer efficacy by oral delivery. Biotechnology. 2019;9:185. doi: 10.1007/s13205-019-1720-x.", "ArticleIdList": ["10.1007/s13205-019-1720-x", "PMC6478784", "31065485"]}, {"Citation": "Wu F., Chen J., Fan L.M., Liu K., Zhang N., Li S.W., Zhu H., Gao H.C. Analysis of the effect of rutin on GSK-3\u03b2 and TNF-\u03b1 expression in lung cancer. Exp. Ther. Med. 2017;14:127\u2013130. doi: 10.3892/etm.2017.4494.", "ArticleIdList": ["10.3892/etm.2017.4494", "PMC5488604", "28672902"]}, {"Citation": "Yeh S.L., Wang W.Y., Huang C.S., Hu M.L. Flavonoids suppresses the enhancing effect of beta-carotene on DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A549 cells. Chem. Biol. Interact. 2006;160:175\u2013182. doi: 10.1016/j.cbi.2006.01.006.", "ArticleIdList": ["10.1016/j.cbi.2006.01.006", "16497287"]}, {"Citation": "Menon L.G., Kuttan R., Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer lett. 1995;95:221\u2013225. doi: 10.1016/0304-3835(95)03887-3.", "ArticleIdList": ["10.1016/0304-3835(95)03887-3", "7656234"]}, {"Citation": "Conesa C.M., Ortega V.V., Y\u00e1\u00f1ez Gasc\u00f3n M.J., Ba\u00f1os M.A., Jordana M.C., Benavente-Garc\u00eda O., Castillo J. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. J. Agric. Food Chem. 2005;53:6791\u20136797. doi: 10.1021/jf058050g.", "ArticleIdList": ["10.1021/jf058050g", "16104801"]}, {"Citation": "Park M.H., Kim S., Song Y.-R., Kim S., Kim H.-J., Na H.S., Chung J. Rutin induces autophagy in cancer cells. Int. J. Oral Biol. 2016;41:45\u201351. doi: 10.11620/IJOB.2016.41.1.045.", "ArticleIdList": ["10.11620/IJOB.2016.41.1.045"]}, {"Citation": "Li X.-H., Liu Z.-Y., Gu Y., Lv Z., Chen Y., Gao H.-C. Expression of NF-kappaB and p38 under intervention of rutin in lung cancer therapy. Biomed Res. 2017;14:2344\u20132347."}, {"Citation": "Guon T.E., Chung H.S. Hyperoside and rutin of Nelumbo nucifera induce mitochondrial apoptosis through a caspase-dependent mechanism in HT-29 human colon cancer cells. Oncol. Lett. 2016;11:2463\u20132470. doi: 10.3892/ol.2016.4247.", "ArticleIdList": ["10.3892/ol.2016.4247", "PMC4812267", "27073499"]}, {"Citation": "Alonso-Castro A.J., Dom\u00ednguez F., Garc\u00eda-Carranc\u00e1 A. Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Arch. Med. Res. 2013;44:346\u2013351. doi: 10.1016/j.arcmed.2013.06.002.", "ArticleIdList": ["10.1016/j.arcmed.2013.06.002", "23867787"]}, {"Citation": "Vijay M., Sivagami G., Thayalan K., Nalini N. Radiosensitizing potential of rutin against human colon adenocarcinoma HT-29 cells. Bratisl. Lek. Listy. 2016;117:171\u2013178. doi: 10.4149/BLL_2016_033.", "ArticleIdList": ["10.4149/BLL_2016_033", "26925749"]}, {"Citation": "Nafees S., Mehdi S.H., Zafaryab M., Zeya B., Sarwar T., Rizvi M.A. Synergistic interaction of rutin and silibinin on human colon cancer cell line. Arch. Med. Res. 2018;49:226\u2013234. doi: 10.1016/j.arcmed.2018.09.008.", "ArticleIdList": ["10.1016/j.arcmed.2018.09.008", "30314650"]}, {"Citation": "Nasrabadi P.N., Zareian S., Nayeri Z., Salmanipour R., Parsafar S., Gharib E., Aghdaei H.A., Zali M.R. A detailed image of rutin underlying intracellular signaling pathways in human SW480 colorectal cancer cells based on miRNAs-lncRNAs-mRNAs-TFs interactions. J. Cell Physiol. 2019;234:15570\u201315580. doi: 10.1002/jcp.28204.", "ArticleIdList": ["10.1002/jcp.28204", "30697726"]}, {"Citation": "Jantrawut P., Akazawa H., Ruksiriwanich W. Anti-cancer activity of rutin encapsulated in low methoxyl pectin beads. Int. J. Pharmcy Pharm. Sci. 2014;6:199\u2013202."}, {"Citation": "Aherne S.A., O\u2019Brien N.M. Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells. Nutr. Cancer. 1999;34:160\u2013166. doi: 10.1207/S15327914NC3402_6.", "ArticleIdList": ["10.1207/S15327914NC3402_6", "10578483"]}, {"Citation": "Aherne S.A., O\u2019Brien N.M. Lack of effect of the flavonoids, myricetin, quercetin, and rutin, on repair of H2O2-induced DNA single-strand breaks in Caco-2, Hep G2, and V79 cells. Nutr. Cancer. 2000;38:106\u2013115. doi: 10.1207/S15327914NC381_15.", "ArticleIdList": ["10.1207/S15327914NC381_15", "11341035"]}, {"Citation": "Deschner E.E., Ruperto J., Wong G., Newmark H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis. 1991;12:1193\u20131196. doi: 10.1093/carcin/12.7.1193.", "ArticleIdList": ["10.1093/carcin/12.7.1193", "2070483"]}, {"Citation": "Volate S.R., Davenport D.M., Muga S.J., Wargovich M.J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin) Carcinogenesis. 2005;26:1450\u20131456. doi: 10.1093/carcin/bgi089.", "ArticleIdList": ["10.1093/carcin/bgi089", "15831530"]}, {"Citation": "Dihal A.A., de Boer V.C., van der Woude H., Tilburgs C., Bruijntjes J.P., Alink G.M., Rietjens I.M., Woutersen R.A., Stierum R.H. Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats. J. Nutr. 2006;136:2862\u20132867. doi: 10.1093/jn/136.11.2862.", "ArticleIdList": ["10.1093/jn/136.11.2862", "17056814"]}, {"Citation": "Volkov\u00e1 M., Forstov\u00e1-K\u0159\u00ed\u017eov\u00e1 V., Sk\u00e1lov\u00e1 L., Trejtnar F. Modulatory effects of quercetin and rutin on the activity, expression and inducibility of CYP1A1 in intestinal HCT-8 cells. Phytother. Res. 2013;27:1889\u20131893. doi: 10.1002/ptr.4992.", "ArticleIdList": ["10.1002/ptr.4992", "24892140"]}, {"Citation": "Wijnands M.V.W., Van Erk M.J., Doornbos R.P., Krul C.A.M., Woutersen R.A. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours. Food Chem. Toxicol. 2004;42:1629\u20131639. doi: 10.1016/j.fct.2004.05.008.", "ArticleIdList": ["10.1016/j.fct.2004.05.008", "15304309"]}, {"Citation": "Santos B., Silva A., Pitanga B., Sousa C., Grangeiro M., Fragomeni B., Coelho P., Oliveira M., Menezes-Filho N., Costa M.F.D., et al. Antiproliferative, proapoptotic and morphogenic effects of the flavonoid rutin on human glioblastoma cells. Food Chem. 2011;127:404\u2013411. doi: 10.1016/j.foodchem.2010.12.131.", "ArticleIdList": ["10.1016/j.foodchem.2010.12.131", "23140679"]}, {"Citation": "Freitas S., Costa S., Azevedo C., Carvalho G., Freire S., Barbosa P., Velozo E., Schaer R., Tardy M., Meyer R., et al. Flavonoids inhibit angiogenic cytokine production by human glioma cells. Phytother. Res. 2011;25:916\u2013921. doi: 10.1002/ptr.3338.", "ArticleIdList": ["10.1002/ptr.3338", "21170924"]}, {"Citation": "Santos B.L., Oliveira M.N., Coelho P.L.C., Pitanga B.P.S., da Silva A.B., Adelita T., Silva V.D.A., Costa M.F.D., El-Bach\u00e1 R.S., Tardy M., et al. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem. Biol. Interact. 2015;242:123\u2013138. doi: 10.1016/j.cbi.2015.07.014.", "ArticleIdList": ["10.1016/j.cbi.2015.07.014", "26408079"]}, {"Citation": "Chen H., Miao Q., Geng M., Liu J., Hu Y., Tian L., Pan J., Yang Y. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci. World J. 2013;2013 doi: 10.1155/2013/269165.", "ArticleIdList": ["10.1155/2013/269165", "PMC3891239", "24459422"]}, {"Citation": "Yan X., Hao Y., Chen S., Jia G., Guo Y., Zhang G., Wang C., Cheng R., Hu T., Zhang X. Rutin induces apoptosis via P53 up-regulation in human glioma CHME cells. Transl. Cancer Res. 2019;8:2005\u20132013. doi: 10.21037/tcr.2019.09.07.", "ArticleIdList": ["10.21037/tcr.2019.09.07", "PMC8798873", "35116949"]}, {"Citation": "Zhang P., Sun S., Li N., Ho A.S.W., Kiang K.M.Y., Zhang X., Cheng Y.S., Poon M.W., Lee D., Pu J.K.S. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition. J. Neurooncol. 2017;132:393\u2013400. doi: 10.1007/s11060-017-2387-y.", "ArticleIdList": ["10.1007/s11060-017-2387-y", "28293765"]}, {"Citation": "Bourogaa E., Bertrand J., Despeaux M., Jarraya R., Fabre N., Payrastre L., Demur C., Fourni\u00e9 J.-J., Damak M., Feki A.E. Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells. Leuk. Res. 2011;35:1093\u20131101. doi: 10.1016/j.leukres.2010.12.011.", "ArticleIdList": ["10.1016/j.leukres.2010.12.011", "21216465"]}, {"Citation": "Lin J.P., Yang J.S., Lin J.J., Lai K.C., Lu H.F., Ma C.Y., Sai-Chuen Wu R., Wu K.C., Chueh F.S., Wood W.G. Rutin inhibits human leukemia tumor growth in a murine xenograft model in vivo. Environ. Toxicol. 2012;27:480\u2013484. doi: 10.1002/tox.20662.", "ArticleIdList": ["10.1002/tox.20662", "21254320"]}, {"Citation": "Lin J.-P., Yang J.-S., Lu C.-C., Chiang J.-H., Wu C.-L., Lin J.-J., Lin H.-L., Yang M.-D., Liu K.-C., Chiu T.-H. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk. Res. 2009;33:823\u2013828. doi: 10.1016/j.leukres.2008.09.032.", "ArticleIdList": ["10.1016/j.leukres.2008.09.032", "19010542"]}, {"Citation": "Chuang C.-H., Huang C.-S., Hu M.-L. Vitamin E and rutin synergistically inhibit expression of vascular endothelial growth factor through down-regulation of binding activity of activator protein-1 in human promyelocytic leukemia (HL-60) cells. Chem. Biol. Interact. 2010;183:434\u2013441. doi: 10.1016/j.cbi.2009.12.007.", "ArticleIdList": ["10.1016/j.cbi.2009.12.007", "20015448"]}, {"Citation": "Ikeda N.E.A., Novak E.M., Maria D.A., Velosa A.S., Pereira R.M.S. Synthesis, characterization and biological evaluation of Rutin\u2013zinc (II) flavonoid-metal complex. Chem. Biol. Interact. 2015;239:184\u2013191. doi: 10.1016/j.cbi.2015.06.011.", "ArticleIdList": ["10.1016/j.cbi.2015.06.011", "26091902"]}, {"Citation": "Horv\u00e1thov\u00e1 K., Novotn\u00fd L., T\u00f3thov\u00e1 D., Vach\u00e1lkov\u00e1 A. Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma. 2004;51:395\u2013399.", "ArticleIdList": ["15640946"]}, {"Citation": "Dedoussis G.V.Z., Kaliora A.C., Andrikopoulos N.K. Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line. Cell Biol. Int. 2005;29:884\u2013889. doi: 10.1016/j.cellbi.2005.07.006.", "ArticleIdList": ["10.1016/j.cellbi.2005.07.006", "16198604"]}, {"Citation": "Shen S.C., Chen Y.C., Hsu F.L., Lee W.R. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J. Cell Biochem. 2003;89:1044\u20131055. doi: 10.1002/jcb.10559.", "ArticleIdList": ["10.1002/jcb.10559", "12874837"]}, {"Citation": "Nadova S., Miadokova E., Cipak L. Flavonoids potentiate the efficacy of cytarabine through modulation of drug-induced apoptosis. Neoplasma. 2007;54:202\u2013206.", "ArticleIdList": ["17447850"]}, {"Citation": "Canturk Z., Dikmen M., Artagan O., Ozarda M.G., Ozturk N. Cytotoxic effects of resveratrol, rutin and rosmarinic acid on ARH\u201377 human (multiple myeloma) cell line. Nat. Prod. Commun. 2016;11:1441\u20131444. doi: 10.1177/1934578X1601101007.", "ArticleIdList": ["10.1177/1934578X1601101007", "30549595"]}, {"Citation": "Prasad R., Banerjee S., Kharshiing C., Bhattacharjee A., Prasad S. Rutin-mediated apoptosis and glutathione changes in ascites daltons lymphoma cells: In silico analysis of rutin interactions with some antiapoptotic and glutathione-related proteins. Indian J. Pharm. Sci. 2019;81:720\u2013728. doi: 10.36468/pharmaceutical-sciences.563.", "ArticleIdList": ["10.36468/pharmaceutical-sciences.563"]}, {"Citation": "Marcarini J.C., Tsuboy M.S.F., Luiz R.C., Ribeiro L.R., Hoffmann-Campo C.B., Mantovani M.S. Investigation of cytotoxic, apoptosis-inducing, genotoxic and protective effects of the flavonoid rutin in HTC hepatic cells. Exp. Toxicol. Pathol. 2011;63:459\u2013465. doi: 10.1016/j.etp.2010.03.005.", "ArticleIdList": ["10.1016/j.etp.2010.03.005", "20399630"]}, {"Citation": "Karakurt S. Modulatory effects of rutin on the expression of cytochrome P450s and antioxidant enzymes in human hepatoma cells. Acta Pharm. 2016;66:491\u2013502. doi: 10.1515/acph-2016-0046.", "ArticleIdList": ["10.1515/acph-2016-0046", "27749250"]}, {"Citation": "Al\u00eda M., Mateos R., Ramos S., Lecumberri E., Bravo L., Goya L. Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2) Eur. J. Nutr. 2006;45:19\u201328. doi: 10.1007/s00394-005-0558-7.", "ArticleIdList": ["10.1007/s00394-005-0558-7", "15782287"]}, {"Citation": "Kim G.N., Jang H.D. Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. Ann. N. Y. Acad. Sci. 2009;1171:530\u2013537. doi: 10.1111/j.1749-6632.2009.04690.x.", "ArticleIdList": ["10.1111/j.1749-6632.2009.04690.x", "19723100"]}, {"Citation": "Labh A.K., Priya V.V., Gayathri R. Cytotoxic action of rutin isolated from Morinda citrifolia against hepatic carcinoma cell lines. Drug Invent. Today. 2019;12:1904\u20131907."}, {"Citation": "Chandra Y.P., Viswanathswamy A. Chemopreventive effect of Rutin against N-nitrosodiethylamine-induced and phenobarbital-promoted hepatocellular carcinoma in Wistar rats. Indian J. Pharm. Educ. Res. 2018;52:78\u201386. doi: 10.5530/ijper.52.1.9.", "ArticleIdList": ["10.5530/ijper.52.1.9"]}, {"Citation": "Webster R., Gawde M., Bhattacharya R. Protective effect of rutin, a flavonol glycoside, on the carcinogen-induced DNA damage and repair enzymes in rats. Cancer Lett. 1996;109:185\u2013191. doi: 10.1016/S0304-3835(96)04443-6.", "ArticleIdList": ["10.1016/S0304-3835(96)04443-6", "9020919"]}, {"Citation": "Li Q., Ren L., Zhang Y., Gu Z., Tan Q., Zhang T., Qin M., Chen S. P38 signal transduction pathway has more cofactors on apoptosis of SGC-7901 gastric cancer cells induced by combination of rutin and oxaliplatin. Biomed. Res. Int. 2019;2019 doi: 10.1155/2019/6407210.", "ArticleIdList": ["10.1155/2019/6407210", "PMC6875277", "31781632"]}, {"Citation": "George K., Malathi R. Influence of the novel anticancer agents on the activity of outward rectifier potassium currents in human prostate cancer cell line-LNCaP. Asian J. Pharm. 2017;11:S603\u2013S608."}, {"Citation": "Roy A.S., Tripathy D.R., Samanta S., Ghosh S.K., Dasgupta S. DNA damaging, cell cytotoxicity and serum albumin binding efficacy of the rutin-Cu(ii) complex. Mol. Biosyst. 2016;12:1687\u20131701. doi: 10.1039/C6MB00161K.", "ArticleIdList": ["10.1039/C6MB00161K", "27035097"]}, {"Citation": "Luo H., Jiang B.H., King S.M., Chen Y.C. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr. Cancer. 2008;60:800\u2013809. doi: 10.1080/01635580802100851.", "ArticleIdList": ["10.1080/01635580802100851", "19005980"]}, {"Citation": "Guruvayoorappan C., Kuttan G. Antiangiogenic effect of rutin and its regulatory effect on the production of VEGF, IL-1\u03b2 and TNF-\u03b1 in tumor associated macrophages. J. Biol. Sci. 2007;7:1511\u20131519. doi: 10.3923/jbs.2007.1511.1519.", "ArticleIdList": ["10.3923/jbs.2007.1511.1519"]}, {"Citation": "Chen J. The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb. Perspect. Med. 2016;6:a026104. doi: 10.1101/cshperspect.a026104.", "ArticleIdList": ["10.1101/cshperspect.a026104", "PMC4772082", "26931810"]}, {"Citation": "Xu B., Li M., Yu Y., He J., Hu S., Pan M., Lu S., Liao K., Pan Z., Zhou Y. Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. Oncol. Lett. 2018;15:1931\u20131936. doi: 10.3892/ol.2017.7495.", "ArticleIdList": ["10.3892/ol.2017.7495", "PMC5774346", "29434892"]}, {"Citation": "Keay S., Nallar S.C., Gade P., Zhang C.-O., Kalvakolanu D.V. Oncosuppressor protein p53 and cyclin-dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expression. Cytokine. 2018;110:110\u2013115. doi: 10.1016/j.cyto.2018.04.029.", "ArticleIdList": ["10.1016/j.cyto.2018.04.029", "29729649"]}, {"Citation": "Munir M.T., Ponce C., Powell C.A., Tarafdar K., Yanagita T., Choudhury M., Gollahon L.S., Rahman S.M. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. J. Steroid Biochem. Mol. Biol. 2018;183:1\u20139. doi: 10.1016/j.jsbmb.2018.05.001.", "ArticleIdList": ["10.1016/j.jsbmb.2018.05.001", "29733910"]}, {"Citation": "Garcia-Estevez L., Moreno-Bueno G. Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res. 2019;21:35. doi: 10.1186/s13058-019-1124-1.", "ArticleIdList": ["10.1186/s13058-019-1124-1", "PMC6397485", "30823902"]}, {"Citation": "Xiao F., Wang C., Yin H., Yu J., Chen S., Fang J., Guo F. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase. Oncotarget. 2016;7:63679. doi: 10.18632/oncotarget.11626.", "ArticleIdList": ["10.18632/oncotarget.11626", "PMC5325395", "27579768"]}, {"Citation": "Wang J., Seebacher N., Shi H., Kan Q., Duan Z. Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget. 2017;8:84559. doi: 10.18632/oncotarget.19187.", "ArticleIdList": ["10.18632/oncotarget.19187", "PMC5663620", "29137448"]}, {"Citation": "Saraswathy M., Gong S. Different strategies to overcome multidrug resistance in cancer. Biotechnol. Adv. 2013;31:1397\u20131407. doi: 10.1016/j.biotechadv.2013.06.004.", "ArticleIdList": ["10.1016/j.biotechadv.2013.06.004", "23800690"]}, {"Citation": "Whitlock B.D., Leslie E.M. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Elsevier; Amsterdam, The Netherlands: 2020. Efflux transporters in anti-cancer drug resistance: Molecular and functional identification and characterization of multidrug resistance proteins (MRPs/ABCCs) pp. 31\u201365."}, {"Citation": "Das M., Law S. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence. Int. J. Biochem. Cell Biol. 2018;103:115\u2013124. doi: 10.1016/j.biocel.2018.08.011.", "ArticleIdList": ["10.1016/j.biocel.2018.08.011", "30153480"]}, {"Citation": "Frascini F., Iriti M., Maestri P., Rimondini L., Catalano E., Megna S. Compositions Comprising Rutin Useful for the Treatment of Tumors Resistant to Chemotherapy. CN Patent Application No. CN105611945A. 2016 May 25;"}, {"Citation": "de Oliveira C.T., Colenci R., Pacheco C.C., Mariano P.M., do Prado P.R., Mamprin G.P.R., Santana M.G., Gambero A., de Carvalho P.O., Priolli D.G. Hydrolyzed rutin decreases worsening of anaplasia in glioblastoma relapse. CNS Neurol. Disord. Drug Targets. 2019;18:405\u2013412. doi: 10.2174/1871527318666190314103104.", "ArticleIdList": ["10.2174/1871527318666190314103104", "30868970"]}, {"Citation": "Moghanjoughi A.A., Khoshnevis D., Zarrabi A. A concise review on smart polymers for controlled drug release. Drug Deliv. Transl. Res. 2016;6:333\u2013340. doi: 10.1007/s13346-015-0274-7.", "ArticleIdList": ["10.1007/s13346-015-0274-7", "26744179"]}, {"Citation": "Gyles D.A., Castro L.D., Silva Jr J.O.C., Ribeiro-Costa R.M. A review of the designs and prominent biomedical advances of natural and synthetic hydrogel formulations. Eur. Polym. J. 2017;88:373\u2013392. doi: 10.1016/j.eurpolymj.2017.01.027.", "ArticleIdList": ["10.1016/j.eurpolymj.2017.01.027"]}, {"Citation": "Cal\u00f3 E., Khutoryanskiy V.V. Biomedical applications of hydrogels: A review of patents and commercial products. Eur. Polym. J. 2015;65:252\u2013267. doi: 10.1016/j.eurpolymj.2014.11.024.", "ArticleIdList": ["10.1016/j.eurpolymj.2014.11.024"]}, {"Citation": "Judd J., Borghaei H. Combining immunotherapy and chemotherapy for non\u2013small cell lung cancer. Thorac. Surg. Clin. 2020;30:199\u2013206. doi: 10.1016/j.thorsurg.2020.01.006.", "ArticleIdList": ["10.1016/j.thorsurg.2020.01.006", "32327178"]}, {"Citation": "Lee K.Y., Shueng P.W., Chou C.M., Lin B.X., Lin M.H., Kuo D.Y., Tsai I.L., Wu S.M., Lin C.W. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling. Cancer Sci. 2020;111:1652. doi: 10.1111/cas.14373.", "ArticleIdList": ["10.1111/cas.14373", "PMC7226182", "32133706"]}, {"Citation": "Gao Y., Liu Z., Zhang X., He J., Pan Y., Hao F., Xie L., Li Q., Qiu X., Wang E. Inhibition of cytoplasmic GSK-3\u03b2 increases cisplatin resistance through activation of Wnt/\u03b2-catenin signaling in A549/DDP cells. Cancer Lett. 2013;336:231\u2013239. doi: 10.1016/j.canlet.2013.05.005.", "ArticleIdList": ["10.1016/j.canlet.2013.05.005", "23673211"]}, {"Citation": "Filla M.S., Dimeo K.D., Tong T., Peters D.M. Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells. Exp. Eye Res. 2017;165:7\u201319. doi: 10.1016/j.exer.2017.08.017.", "ArticleIdList": ["10.1016/j.exer.2017.08.017", "PMC5705399", "28860021"]}, {"Citation": "Lee J.K., Kim N.-J. Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease. Molecules. 2017;22:1287. doi: 10.3390/molecules22081287.", "ArticleIdList": ["10.3390/molecules22081287", "PMC6152076", "28767069"]}, {"Citation": "Stramucci L., Pranteda A., Bossi G. Insights of crosstalk between p53 protein and the MKK3/MKK6/p38 MAPK signaling pathway in cancer. Cancers. 2018;10:131. doi: 10.3390/cancers10050131.", "ArticleIdList": ["10.3390/cancers10050131", "PMC5977104", "29751559"]}, {"Citation": "Bradham C., McClay D.R. p38 MAPK in development and cancer. Cell Cycle. 2006;5:824\u2013828. doi: 10.4161/cc.5.8.2685.", "ArticleIdList": ["10.4161/cc.5.8.2685", "16627995"]}, {"Citation": "Johnson C.M., Wei C., Ensor J.E., Smolenski D.J., Amos C.I., Levin B., Berry D.A. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207\u20131222. doi: 10.1007/s10552-013-0201-5.", "ArticleIdList": ["10.1007/s10552-013-0201-5", "PMC4161278", "23563998"]}, {"Citation": "Zhou L., Wang S., Cao L., Ren X., Li Y., Shao J., Xu L. Lead acetate induces apoptosis in Leydig cells by activating PPAR\u03b3/caspase-3/PARP pathway. Int. J. Environ. Health Res. 2019:1\u201311. doi: 10.1080/09603123.2019.1625034.", "ArticleIdList": ["10.1080/09603123.2019.1625034", "31145012"]}, {"Citation": "Qi X., Du L., Chen X., Chen L., Yi T., Chen X., Wen Y., Wei Y., Zhao X. VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein. Int. J. Oncol. 2016;49:123\u2013132. doi: 10.3892/ijo.2016.3527.", "ArticleIdList": ["10.3892/ijo.2016.3527", "PMC4902071", "27211072"]}, {"Citation": "Todoric J., Antonucci L., Karin M. Targeting inflammation in cancer prevention and therapy. Cancer Prev. Res. 2016;9:895\u2013905. doi: 10.1158/1940-6207.CAPR-16-0209.", "ArticleIdList": ["10.1158/1940-6207.CAPR-16-0209", "PMC5142754", "27913448"]}, {"Citation": "Jiangjiang Q., Wei W., Zhang R. Novel natural product therapeutics targeting both inflammation and cancer. Chin. J. Nat. Med. 2017;15:401\u2013416.", "ArticleIdList": ["PMC6663108", "28629530"]}, {"Citation": "Fakhri S., Moradi S.Z., Farzaei M.H., Bishayee A. Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review. Semin. Cancer Biol. 2020 doi: 10.1016/j.semcancer.2020.02.007. in press.", "ArticleIdList": ["10.1016/j.semcancer.2020.02.007", "32081639"]}, {"Citation": "Su S., Wang J., Vargas E., Wei J., Mart\u00ednez-Zaguil\u00e1n R., Sennoune S.R., Pantoya M.L., Wang S., Chaudhuri J., Qiu J. Porphyrin immobilized nanographene oxide for enhanced and targeted photothermal therapy of brain cancer. ACS Biomater. Sci. Eng. 2016;2:1357\u20131366. doi: 10.1021/acsbiomaterials.6b00290.", "ArticleIdList": ["10.1021/acsbiomaterials.6b00290", "33434989"]}, {"Citation": "Lewinska A., Adamczyk-Grochala J., Kwasniewicz E., Deregowska A., Wnuk M. Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity. Toxicol. Lett. 2017;265:117\u2013130. doi: 10.1016/j.toxlet.2016.11.018.", "ArticleIdList": ["10.1016/j.toxlet.2016.11.018", "27890807"]}, {"Citation": "Cagnol S., Chambard J.C. ERK and cell death: Mechanisms of ERK-induced cell death\u2013apoptosis, autophagy and senescence. FEBS J. 2010;277:2\u201321. doi: 10.1111/j.1742-4658.2009.07366.x.", "ArticleIdList": ["10.1111/j.1742-4658.2009.07366.x", "19843174"]}, {"Citation": "Sivaprasad U., Basu A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-\u03b1-induced cell death in MCF-7 cells. J. Cell Mol. Med. 2008;12:1265\u20131271. doi: 10.1111/j.1582-4934.2008.00282.x.", "ArticleIdList": ["10.1111/j.1582-4934.2008.00282.x", "PMC3865671", "18266953"]}, {"Citation": "Zeid R., Lawlor M.A., Poon E., Reyes J.M., Fulciniti M., Lopez M.A., Scott T.G., Nabet B., Erb M.A., Winter G.E. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat. Genet. 2018;50:515\u2013523. doi: 10.1038/s41588-018-0044-9.", "ArticleIdList": ["10.1038/s41588-018-0044-9", "PMC6310397", "29379199"]}, {"Citation": "Moosavi M.A., Haghi A., Rahmati M., Taniguchi H., Mocan A., Echeverr\u00eda J., Gupta V.K., Tzvetkov N.T., Atanasov A.G. Phytochemicals as potent modulators of autophagy for cancer therapy. Cancer Lett. 2018;424:46\u201369. doi: 10.1016/j.canlet.2018.02.030.", "ArticleIdList": ["10.1016/j.canlet.2018.02.030", "29474859"]}, {"Citation": "Fulda S. Autophagy in cancer therapy. Front. Oncol. 2017;7:128. doi: 10.3389/fonc.2017.00128.", "ArticleIdList": ["10.3389/fonc.2017.00128", "PMC5475391", "28674677"]}, {"Citation": "Vasilevskaya I.A., Selvakumaran M., Roberts D., O\u2019Dwyer P.J. JNK1 inhibition attenuates hypoxia-induced autophagy and sensitizes to chemotherapy. Mol. Cancer Res. 2016;14:753\u2013763. doi: 10.1158/1541-7786.MCR-16-0035.", "ArticleIdList": ["10.1158/1541-7786.MCR-16-0035", "PMC4987255", "27216154"]}, {"Citation": "Saultz J.N., Garzon R. Acute myeloid leukemia: A concise review. J. Clin. Med. 2016;5:33. doi: 10.3390/jcm5030033.", "ArticleIdList": ["10.3390/jcm5030033", "PMC4810104", "26959069"]}, {"Citation": "Reddiconto G., Toto C., Palam\u00e0 I., De Leo S., De Luca E., De Matteis S., Dini L., Passerini C.G., Di Renzo N., Maffia M. Targeting of GSK3\u03b2 promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells. Blood. 2012;119:2335\u20132345. doi: 10.1182/blood-2011-06-361261.", "ArticleIdList": ["10.1182/blood-2011-06-361261", "22262776"]}, {"Citation": "Wang Z., Jin C., Li X., Ding K. Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Carbohydr. Polym. 2019;207:502\u2013509. doi: 10.1016/j.carbpol.2018.11.091.", "ArticleIdList": ["10.1016/j.carbpol.2018.11.091", "30600033"]}, {"Citation": "Eferl R., Wagner E.F. AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer. 2003;3:859\u2013868. doi: 10.1038/nrc1209.", "ArticleIdList": ["10.1038/nrc1209", "14668816"]}, {"Citation": "Cheng J., Yang H.L., Gu C.J., Liu Y.K., Shao J., Zhu R., He Y.Y., Zhu X.Y., Li M.Q. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1\u03b1/ROS/VEGF. Int. J. Mol. Med. 2019;43:945\u2013955. doi: 10.3892/ijmm.2018.4021.", "ArticleIdList": ["10.3892/ijmm.2018.4021", "PMC6317691", "30569127"]}, {"Citation": "Lai J., Chen F., Chen J., Ruan G., He M., Chen C., Tang J., Wang D.W. Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling. Sci. Rep. 2017;7:1\u201311. doi: 10.1038/srep44473.", "ArticleIdList": ["10.1038/srep44473", "PMC5349602", "28290552"]}, {"Citation": "Affo S., Yu L.-X., Schwabe R.F. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev. Pathol. 2017;12:153\u2013186. doi: 10.1146/annurev-pathol-052016-100322.", "ArticleIdList": ["10.1146/annurev-pathol-052016-100322", "PMC5720358", "27959632"]}, {"Citation": "Abbasi B.H., Nazir M., Muhammad W., Hashmi S.S., Abbasi R., Rahman L., Hano C. A comparative evaluation of the antiproliferative activity against Hepg2 liver carcinoma cells of plant-derived silver nanoparticles from basil extracts with contrasting anthocyanin contents. Biomolecules. 2019;9:320. doi: 10.3390/biom9080320.", "ArticleIdList": ["10.3390/biom9080320", "PMC6722760", "31366167"]}, {"Citation": "Wang Q.-L., Wu Q., Tao Y.-Y., Liu C.-H., El-Nezami H. Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells. Hepatobiliary Pancreat. Dis. Int. 2011;10:502\u2013508. doi: 10.1016/S1499-3872(11)60085-4.", "ArticleIdList": ["10.1016/S1499-3872(11)60085-4", "21947724"]}, {"Citation": "Aloud A.A., Veeramani C., Govindasamy C., Alsaif M.A., Al-Numair K.S. Galangin ameliorates changes of membrane\u2013bound enzymes in rats with streptozotocin\u2013induced hyperglycemia. Asian Pac. J. Trop. Biomed. 2019;9:284."}, {"Citation": "Rajamanickam E., Gurudeeban S., Satyavani K., Ramanathan T. Chemopreventive effect of Acanthus ilicifolius extract on modulating antioxidants, lipid peroxidation and membrane bound enzymes in diethyl nitrosamine induced liver carcinogenesis. Int. J. Cancer Res. 2016;12:1\u201316."}, {"Citation": "Nriagu J., Darroudi F., Shomar B. Health effects of desalinated water: Role of electrolyte disturbance in cancer development. Environ. Res. 2016;150:191\u2013204. doi: 10.1016/j.envres.2016.05.038.", "ArticleIdList": ["10.1016/j.envres.2016.05.038", "27295409"]}, {"Citation": "Wang Y., Chen X., Sun Q., Zang W., Li M., Dong Z., Zhao G. Retraction note: Overexpression of A613T and G462T variants of DNA polymerase \u03b2 weakens chemotherapy sensitivity in esophageal cancer cell lines. Cancer Cell Int. 2019;19:19. doi: 10.1186/s12935-019-0814-1.", "ArticleIdList": ["10.1186/s12935-019-0814-1", "PMC6452508", "30996688"]}, {"Citation": "Sallmyr A., Matsumoto Y., Roginskaya V., Van Houten B., Tomkinson A.E. Inhibiting mitochondrial DNA ligase III\u03b1 activates caspase 1\u2013Dependent apoptosis in cancer cells. Cancer Res. 2016;76:5431\u20135441. doi: 10.1158/0008-5472.CAN-15-3243.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-3243", "PMC5036517", "27503931"]}, {"Citation": "Lin K.Y., Kraus W.L. PARP inhibitors for cancer therapy. Cell. 2017;169:183. doi: 10.1016/j.cell.2017.03.034.", "ArticleIdList": ["10.1016/j.cell.2017.03.034", "28388401"]}, {"Citation": "Haghi A., Azimi H., Rahimi R. A comprehensive review on pharmacotherapeutics of three phytochemicals, curcumin, quercetin, and allicin, in the treatment of gastric cancer. J. Gastrointest. Cancer. 2017;48:314\u2013320. doi: 10.1007/s12029-017-9997-7.", "ArticleIdList": ["10.1007/s12029-017-9997-7", "28828709"]}, {"Citation": "Berlth F., Bollschweiler E., Drebber U., Hoelscher A.H., Moenig S. Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J. Gastroenterol. 2014;20:5679. doi: 10.3748/wjg.v20.i19.5679.", "ArticleIdList": ["10.3748/wjg.v20.i19.5679", "PMC4024777", "24914328"]}, {"Citation": "Sitarz R., Skierucha M., Mielko J., Offerhaus G.J.A., Maciejewski R., Polkowski W.P. Gastric cancer: Epidemiology, prevention, classification, and treatment. Cancer Manag. Res. 2018;10:239. doi: 10.2147/CMAR.S149619.", "ArticleIdList": ["10.2147/CMAR.S149619", "PMC5808709", "29445300"]}, {"Citation": "Ren L.-Q., Li Q., Zhang Y. Luteolin suppresses the proliferation of gastric cancer cells and acts in synergy with oxaliplatin. Biomed. Res. Int. 2020;2020 doi: 10.1155/2020/9396512.", "ArticleIdList": ["10.1155/2020/9396512", "PMC7057019", "32149146"]}, {"Citation": "Zou X., Blank M. Targeting p38 MAP kinase signaling in cancer through post-translational modifications. Cancer Lett. 2017;384:19\u201326. doi: 10.1016/j.canlet.2016.10.008.", "ArticleIdList": ["10.1016/j.canlet.2016.10.008", "27725227"]}, {"Citation": "Mart\u00ednez-Lim\u00f3n A., Joaquin M., Caballero M., Posas F., de Nadal E. The p38 pathway: From biology to cancer therapy. Int. J. Mol. Sci. 2020;21:1913. doi: 10.3390/ijms21061913.", "ArticleIdList": ["10.3390/ijms21061913", "PMC7139330", "32168915"]}, {"Citation": "Kawan M.A., Kyrou I., Ramanjaneya M., Williams K., Jeyaneethi J., Randeva H.S., Karteris E. Involvement of the glutamine RF-amide peptide and its cognate receptor GPR103 in prostate cancer. Oncol. Rep. 2019;41:1140\u20131150. doi: 10.3892/or.2018.6893.", "ArticleIdList": ["10.3892/or.2018.6893", "PMC6313030", "30483810"]}, {"Citation": "Abidi S.H., Bilwani F., Ghias K., Abbas F. Viral etiology of prostate cancer: Genetic alterations and immune response. A literature review. Int. J. Surg. 2018;52:136\u2013140. doi: 10.1016/j.ijsu.2018.02.050.", "ArticleIdList": ["10.1016/j.ijsu.2018.02.050", "29496646"]}, {"Citation": "de J\u00fanior R.G.O., Adrielly A.F.C., da Almeida J.R.G.S., Grougnet R., Thi\u00e9ry V., Picot L. Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms. Fitoterapia. 2018;129:383\u2013400. doi: 10.1016/j.fitote.2018.02.025.", "ArticleIdList": ["10.1016/j.fitote.2018.02.025", "29476786"]}, {"Citation": "Abdul M., Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett. 2002;186:99\u2013105. doi: 10.1016/S0304-3835(02)00348-8.", "ArticleIdList": ["10.1016/S0304-3835(02)00348-8", "12183081"]}, {"Citation": "Flahaut M., Meier R., Coulon A., Nardou K., Niggli F., Martinet D., Beckmann J., Joseph J., M\u00fchlethaler-Mottet A., Gross N. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/\u03b2-catenin pathway. Oncogene. 2009;28:2245\u20132256. doi: 10.1038/onc.2009.80.", "ArticleIdList": ["10.1038/onc.2009.80", "19421142"]}, {"Citation": "Lheureux S., Braunstein M., Oza A.M. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J. Clin. 2019;69:280\u2013304. doi: 10.3322/caac.21559.", "ArticleIdList": ["10.3322/caac.21559", "31099893"]}, {"Citation": "Pashaei-Asl F., Pashaei-Asl R., Khodadadi K., Akbarzadeh A., Ebrahimie E., Pashaiasl M. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Artif. Cells Nanomed. Biotechnol. 2018;46:1483\u20131487. doi: 10.1080/21691401.2017.1374281.", "ArticleIdList": ["10.1080/21691401.2017.1374281", "28884602"]}, {"Citation": "Miyake K., Arima H., Hirayama F., Yamamoto M., Horikawa T., Sumiyoshi H., Noda S., Uekama K. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-\u03b2-cyclodextrin. Pharm. Dev. Technol. 2000;5:399\u2013407. doi: 10.1081/PDT-100100556.", "ArticleIdList": ["10.1081/PDT-100100556", "10934740"]}, {"Citation": "Arora D., Jaglan S. Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments. Trends Food Sci Technol. 2016;54:114\u2013126. doi: 10.1016/j.tifs.2016.06.003.", "ArticleIdList": ["10.1016/j.tifs.2016.06.003"]}, {"Citation": "Kashyap D., Tuli H.S., Yerer M.B., Sharma A., Sak K., Srivastava S., Pandey A., Garg V.K., Sethi G., Bishayee A. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin. Cancer Biol. 2019 doi: 10.1016/j.semcancer.2019.08.014. in press.", "ArticleIdList": ["10.1016/j.semcancer.2019.08.014", "31421264"]}, {"Citation": "Lagoa R., Silva J., Rodrigues J.R., Bishayee A. Advances in phytochemical delivery systems for improved anticancer activity. Biotechnol. Adv. 2020;38:107382. doi: 10.1016/j.biotechadv.2019.04.004.", "ArticleIdList": ["10.1016/j.biotechadv.2019.04.004", "30978386"]}, {"Citation": "McClements D.J. Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals. Biotechnol. Adv. 2020;38:107287. doi: 10.1016/j.biotechadv.2018.08.004.", "ArticleIdList": ["10.1016/j.biotechadv.2018.08.004", "30086329"]}, {"Citation": "Nel A., Ruoslahti E., Meng H. New insights into \u201cpermeability\u201d as in the enhanced permeability and retention effect of cancer nanotherapeutics. ACS Nano. 2017 doi: 10.1021/acsnano.7b07214.", "ArticleIdList": ["10.1021/acsnano.7b07214", "29065443"]}, {"Citation": "Kalyane D., Raval N., Maheshwari R., Tambe V., Kalia K., Tekade R.K. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater. Sci. Eng. C. 2019;98:1252\u20131276. doi: 10.1016/j.msec.2019.01.066.", "ArticleIdList": ["10.1016/j.msec.2019.01.066", "30813007"]}, {"Citation": "Muhamad N., Plengsuriyakarn T., Na-Bangchang K. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: A systematic review. Int. J. Nanomed. 2018;13:3921. doi: 10.2147/IJN.S165210.", "ArticleIdList": ["10.2147/IJN.S165210", "PMC6038858", "30013345"]}, {"Citation": "Kunjiappan S., Panneerselvam T., Govindaraj S., Parasuraman P., Baskararaj S., Sankaranarayanan M., Arunachalam S., Babkiewicz E., Jeyakumar A., Lakshmanan M. Design, in silico modelling, and functionality theory of novel folate receptor targeted rutin encapsulated folic acid conjugated keratin nanoparticles for effective cancer treatment. Anticancer Agents Med. Chem. 2019;19:1966\u20131982. doi: 10.2174/1871520619666190702145609.", "ArticleIdList": ["10.2174/1871520619666190702145609", "31267878"]}, {"Citation": "Ge L., He X., Zhang Y., Zhang Y., Chai F., Jiang L., Webster T.J., Zheng C. A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract. Nanomedicine. 2018;14:1455\u20131464. doi: 10.1016/j.nano.2017.08.009.", "ArticleIdList": ["10.1016/j.nano.2017.08.009", "28842377"]}, {"Citation": "Khan W., Ansari V.A., Hussain Z., Siddique N.F. Nanoemulsion: A Droplet Nanocarrier System for Enhancing Bioavailability of Poorly Water Soluble Drugs. Res. J. Pharm. Technol. 2018;11:5191\u20135196. doi: 10.5958/0974-360X.2018.00948.4.", "ArticleIdList": ["10.5958/0974-360X.2018.00948.4"]}, {"Citation": "Ahmad M., Sahabjada J.A., Hussain A., Badaruddeen M.A., Mishra A. Development of a new rutin nanoemulsion and its application on prostate carcinoma PC3 cell line. Excli. J. 2017;16:810.", "ArticleIdList": ["PMC5500835", "28694767"]}, {"Citation": "Caparica R., J\u00falio A., Ara\u00fajo M.E.M., Baby A.R., Fonte P., Costa J.G., Santos de Almeida T. Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells. Biomolecules. 2020;10:233. doi: 10.3390/biom10020233.", "ArticleIdList": ["10.3390/biom10020233", "PMC7072522", "32033222"]}, {"Citation": "Asfour M.H., Mohsen A.M. Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line. J. Adv. Res. 2018;9:17\u201326. doi: 10.1016/j.jare.2017.10.003.", "ArticleIdList": ["10.1016/j.jare.2017.10.003", "PMC6052648", "30034879"]}, {"Citation": "Kunjiappan S., Panneerselvam T., Somasundaram B., Sankaranarayanan M., Chowdhury R., Chowdhury A., Bhattacharjee C. Design, in silico modeling, biodistribution study of rutin and quercetin loaded stable human hair keratin nanoparticles intended for anticancer drug delivery. Biomed. Phys. Eng. Express. 2018;4:025019. doi: 10.1088/2057-1976/aaa1cf.", "ArticleIdList": ["10.1088/2057-1976/aaa1cf"]}, {"Citation": "Pandey P., Rahman M., Bhatt P.C., Beg S., Paul B., Hafeez A., Al-Abbasi F.A., Nadeem M.S., Baothman O., Anwar F. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine. 2018;13:849\u2013870. doi: 10.2217/nnm-2017-0306.", "ArticleIdList": ["10.2217/nnm-2017-0306", "29565220"]}, {"Citation": "Deepika M.S., Thangam R., Sheena T.S., Vimala R., Sivasubramanian S., Jeganathan K., Thirumurugan R. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy. Mater. Sci. Eng. C. 2019;103:109716. doi: 10.1016/j.msec.2019.05.001.", "ArticleIdList": ["10.1016/j.msec.2019.05.001", "31349431"]}, {"Citation": "Chang C., Zhang L., Miao Y., Fang B., Yang Z. Anticancer and apoptotic-inducing effects of rutin-chitosan nanoconjugates in triple negative breast cancer cells. J. Clust. Sci. 2020:1\u201310. doi: 10.1007/s10876-020-01792-w.", "ArticleIdList": ["10.1007/s10876-020-01792-w"]}, {"Citation": "Bharathi D., Bhuvaneshwari V. Synthesis of zinc oxide nanoparticles (ZnO NPs) using pure bioflavonoid rutin and their biomedical applications: Antibacterial, antioxidant and cytotoxic activities. Res. Chem. Intermediat. 2019;45:2065\u20132078. doi: 10.1007/s11164-018-03717-9.", "ArticleIdList": ["10.1007/s11164-018-03717-9"]}, {"Citation": "Bharathi D., Ranjithkumar R., Chandarshekar B., Bhuvaneshwari V. Bio-inspired synthesis of chitosan/copper oxide nanocomposite using rutin and their anti-proliferative activity in human lung cancer cells. Int. J. Biol. Macromol. 2019;141:476\u2013483. doi: 10.1016/j.ijbiomac.2019.08.235.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.08.235", "31473316"]}, {"Citation": "Deepika M.S., Thangam R., Sheena T.S., Sasirekha R., Sivasubramanian S., Babu M.D., Jeganathan K., Thirumurugan R. A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomed. Pharmacother. 2019;109:1181\u20131195. doi: 10.1016/j.biopha.2018.10.178.", "ArticleIdList": ["10.1016/j.biopha.2018.10.178", "30551368"]}, {"Citation": "Radwan R.R., Ali H.E. Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma. Drug Deliv. Transl. Res. 2020 doi: 10.1007/s13346-020-00792-7.", "ArticleIdList": ["10.1007/s13346-020-00792-7", "32488816"]}, {"Citation": "Khonkarn R., Daowtak K., Okonogi S. Chemotherapeutic efficacy enhancement in P-gp-Overexpressing cancer cells by flavonoid-loaded polymeric micelles. AAPS Pharm. Sci. Tech. 2020;21:121. doi: 10.1208/s12249-020-01657-5.", "ArticleIdList": ["10.1208/s12249-020-01657-5", "32337630"]}, {"Citation": "J\u00falio A., Antunes C., Mineiro R., Raposo M., Caparica R., Ara\u00fajo M., Rosado C., Fonte P., Santos de Almeida T. Influence of two choline-based ionic liquids on the solubility of caffeine. J. Biomed. Biopharm. Res. 2018;15:96\u2013102. doi: 10.19277/BBR.15.1.178.", "ArticleIdList": ["10.19277/BBR.15.1.178"]}, {"Citation": "Caparica R., J\u00falio A., Rosado C., Santos de Almeida T. Applicability of ionic liquids in topical drug delivery systems: A mini review. J. Pharmacol. Clin. Res. 2018;4:555649\u2013555655. doi: 10.19080/JPCR.2018.04.555649.", "ArticleIdList": ["10.19080/JPCR.2018.04.555649"]}, {"Citation": "Khezeli T., Ghaedi M., Daneshfar A., Bahrani S., Asfaram A., Soylak M. New Generation Green Solvents for Separation and Preconcentration of Organic and Inorganic Species. Elsevier; Amsterdam, The Netherlands: 2020. Ionic liquids in separation and preconcentration of organic and inorganic species; pp. 267\u2013318."}, {"Citation": "Kumar S.S.D., Surianarayanan M., Vijayaraghavan R., Mandal A.B., Macfarlane D.R. Curcumin loaded poly (2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid\u2013In vitro cytotoxicity and anti-cancer activity in SKOV-3 cells. Eur. J. Pharm. Sci. 2014;51:34\u201344. doi: 10.1016/j.ejps.2013.08.036.", "ArticleIdList": ["10.1016/j.ejps.2013.08.036", "24012589"]}, {"Citation": "Chowdhury M.R., Moshikur R.M., Wakabayashi R., Tahara Y., Kamiya N., Moniruzzaman M., Goto M. Ionic-liquid-based paclitaxel preparation: A new potential formulation for cancer treatment. Mol. Pharm. 2018;15:2484\u20132488. doi: 10.1021/acs.molpharmaceut.8b00305.", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b00305", "29762034"]}, {"Citation": "Karimi M., Eslami M., Sahandi-Zangabad P., Mirab F., Farajisafiloo N., Shafaei Z., Ghosh D., Bozorgomid M., Dashkhaneh F., Hamblin M.R. pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip. Rev. Nanomed Nanobiotechnol. 2016;8:696\u2013716. doi: 10.1002/wnan.1389.", "ArticleIdList": ["10.1002/wnan.1389", "PMC4945487", "26762467"]}, {"Citation": "Cheng R., Meng F., Deng C., Klok H.-A., Zhong Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials. 2013;34:3647\u20133657. doi: 10.1016/j.biomaterials.2013.01.084.", "ArticleIdList": ["10.1016/j.biomaterials.2013.01.084", "23415642"]}, {"Citation": "Liu M., Du H., Zhang W., Zhai G. Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications. Mater. Sci. Eng. C. 2017;71:1267\u20131280. doi: 10.1016/j.msec.2016.11.030.", "ArticleIdList": ["10.1016/j.msec.2016.11.030", "27987683"]}, {"Citation": "Fathi M., Zangabad P.S., Majidi S., Barar J., Erfan-Niya H., Omidi Y. Stimuli-responsive chitosan-based nanocarriers for cancer therapy. BioImpacts. 2017;7:269. doi: 10.15171/bi.2017.32.", "ArticleIdList": ["10.15171/bi.2017.32", "PMC5801539", "29435435"]}, {"Citation": "Chawla A., Sharma P., Pawar P. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: Formulation, optimization and in vitro evaluation/Alginatne mikrosfere naproksen natrija oblo\u017eene Eudragitom S-100: Priprava, optimizacija i in vitro vrednovanje. Acta Pharm. 2012;62:529\u2013545. doi: 10.2478/v10007-012-0034-x.", "ArticleIdList": ["10.2478/v10007-012-0034-x", "23333888"]}, {"Citation": "Madhavi M., Madhavi K., Jithan A. Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer. J. Pharm. Bioallied Sci. 2012;4:164.", "ArticleIdList": ["PMC3341721", "22557928"]}, {"Citation": "Tarhini M., Greige-Gerges H., Elaissari A. Protein-based nanoparticles: From preparation to encapsulation of active molecules. Int. J. Pharm. 2017;522:172\u2013197. doi: 10.1016/j.ijpharm.2017.01.067.", "ArticleIdList": ["10.1016/j.ijpharm.2017.01.067", "28188876"]}, {"Citation": "Sharma S., Gupta A. Sustainable management of keratin waste biomass: Applications and future perspectives. Braz. Arch. Biol. Technol. 2016;59 doi: 10.1590/1678-4324-2016150684.", "ArticleIdList": ["10.1590/1678-4324-2016150684"]}, {"Citation": "Lee Y.-H., Lai Y.-H. Synthesis, characterization, and biological evaluation of anti-her2 indocyanine green-encapsulated peg-coated plga nanoparticles for targeted phototherapy of breast cancer cells. PLoS ONE. 2016;11:e0168192. doi: 10.1371/journal.pone.0168192.", "ArticleIdList": ["10.1371/journal.pone.0168192", "PMC5152925", "27942034"]}, {"Citation": "Wang H., Zhao Y., Wu Y., Hu Y.-l., Nan K., Nie G., Chen H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32:8281\u20138290. doi: 10.1016/j.biomaterials.2011.07.032.", "ArticleIdList": ["10.1016/j.biomaterials.2011.07.032", "21807411"]}, {"Citation": "Song X., Zhao Y., Hou S., Xu F., Zhao R., He J., Cai Z., Li Y., Chen Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm. 2008;69:445\u2013453. doi: 10.1016/j.ejpb.2008.01.013.", "ArticleIdList": ["10.1016/j.ejpb.2008.01.013", "18374554"]}, {"Citation": "Mugaka B.P., Hu Y., Ma Y., Ding Y. Surface Modification of Nanoparticles for Targeted Drug Delivery. Springer; Berlin/Heidelberg, Germany: 2019. Surface modification of gold nanoparticles for targeted drug delivery; pp. 391\u2013403."}, {"Citation": "Ovais M., Khalil A.T., Raza A., Khan M.A., Ahmad I., Islam N.U., Saravanan M., Ubaid M.F., Ali M., Shinwari Z.K. Green synthesis of silver nanoparticles via plant extracts: Beginning a new era in cancer theranostics. Nanomedicine. 2016;12:3157\u20133177. doi: 10.2217/nnm-2016-0279.", "ArticleIdList": ["10.2217/nnm-2016-0279", "27809668"]}, {"Citation": "Sharma H., Mishra P.K., Talegaonkar S., Vaidya B. Metal nanoparticles: A theranostic nanotool against cancer. Drug Discov. Today. 2015;20:1143\u20131151. doi: 10.1016/j.drudis.2015.05.009.", "ArticleIdList": ["10.1016/j.drudis.2015.05.009", "26007605"]}, {"Citation": "Wu L., Sun J., Su X., Yu Q., Yu Q., Zhang P. A review about the development of fucoidan in antitumor activity: Progress and challenges. Carbohydr. Polym. 2016;154:96\u2013111. doi: 10.1016/j.carbpol.2016.08.005.", "ArticleIdList": ["10.1016/j.carbpol.2016.08.005", "27577901"]}, {"Citation": "Chmit M., Kanaan H., Habib J., Abbass M., Mcheik A., Chokr A. Antibacterial and antibiofilm activities of polysaccharides, essential oil, and fatty oil extracted from Laurus nobilis growing in Lebanon. Asian Pac. J. Trop Med. 2014;7:S546\u2013S552. doi: 10.1016/S1995-7645(14)60288-1.", "ArticleIdList": ["10.1016/S1995-7645(14)60288-1", "25312182"]}, {"Citation": "Bartlett M.R., Warren H.S., Cowden W.B., Parish C.R. Effects of the anti-inflammatory compounds castanospermine, mannose-6-phosphate and fucoidan on allograft rejection and elicited peritoneal exudates. Immunol. Cell Biol. 1994;72:367\u2013374. doi: 10.1038/icb.1994.55.", "ArticleIdList": ["10.1038/icb.1994.55", "7835980"]}, {"Citation": "Phan N.H., Ly T.T., Pham M.N., Luu T.D., Vo T.V., Tran P.H., Tran T.T. A comparison of fucoidan conjugated to paclitaxel and curcumin for the dual delivery of cancer therapeutic agents. Anticancer Agents Med. Chem. 2018;18:1349\u20131355. doi: 10.2174/1871520617666171121125845.", "ArticleIdList": ["10.2174/1871520617666171121125845", "29173183"]}, {"Citation": "Lu K.-Y., Li R., Hsu C.-H., Lin C.-W., Chou S.-C., Tsai M.-L., Mi F.-L. Development of a new type of multifunctional fucoidan-based nanoparticles for anticancer drug delivery. Carbohydr. Polym. 2017;165:410\u2013420. doi: 10.1016/j.carbpol.2017.02.065.", "ArticleIdList": ["10.1016/j.carbpol.2017.02.065", "28363567"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "6"}, {"Year": "2020", "Month": "8", "Day": "7"}, {"Year": "2020", "Month": "8", "Day": "10"}, {"Year": "2020", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["32823876", "PMC7463935", "10.3390/cancers12082276", "cancers12082276"]}}]}